Thursday, December 13, 2012
AstraZeneca plc and Pfizer Inc. have partnered with
the Quebec government to form the not-for-profit Neomed Institute. The drug
development institute will resume work on pain compounds discontinued by
AstraZeneca earlier this year and plans to build a new pipeline through
collaborations with regional academic laboratories and biotech startups.
L. SciBX 5(48);
Published online Dec. 13, 2012
1. Hansen, S. BioCentury
20(8), A7; Feb. 20, 2012
AND INSTITUTIONS MENTIONED
AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K.
Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J.
Neomed Institute, Montreal, Quebec, Canada
Pfizer Inc. (NYSE:PFE), New York, N.Y.
Quebec Consortium for Drug Discovery, Nuns' Island, Quebec, Canada